REQUEST A DEMO
Total
USD $0.00
Search more companies

Adipharm EAD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Adipharm EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Adipharm was established in 1994 by Syrian businessman - Abdul Sahtura. The company manufactures pharmaceuticals and food supplements. It operates a 4,000 square meters production facility with an annual capacity of more than 950 million tablets and 300 million capsules. Adipahrm is working in cooperation with Polish Polpharma and Spain's Chemo.

Headquarters
Simeonovsko Shose 130
Sofia; Sofia - city; Postal Code: 1700

Contact Details: Purchase the Adipharm EAD report to view the information.

Website: http://www.adipharm.com

Basic Information
Total Employees:
Purchase the Adipharm EAD report to view the information.
Outstanding Shares:
Purchase the Adipharm EAD report to view the information.
Registered Capital:
Purchase the Adipharm EAD report to view the information.
Financial Auditors:
Purchase the Adipharm EAD report to view the information.
Incorporation Date:
June 24, 1994
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Adipharm EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
4.42%
Total operating revenue
1.99%
Operating profit (EBIT)
42.16%
EBITDA
6.1%
Net Profit (Loss) for the Period
60.71%
Total assets
0.17%
Total equity
-0.03%
Operating Profit Margin (ROS)
6.19%
Net Profit Margin
7.59%
Return on Equity (ROE)
6.12%
Debt to Equity Ratio
-0.78%
Quick Ratio
-0.1%
Cash Ratio
-0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?